Filter
1292
Filtered Results: 1292
Text search:
drug
susceptibility
Featured
Recommendations
158
New Publications
312
Language
Document type
No document type
722
Guidelines
222
Studies & Reports
210
Manuals
57
Strategic & Response Plan
36
Fact sheets
19
Training Material
14
Situation Updates
10
Online Courses
2
Countries / Regions
India
63
Western and Central Europe
44
Ethiopia
32
Eastern Europe
31
Kenya
30
Latin America and the Carribbean
28
South Africa
24
Global
21
Africa
21
Tanzania
19
Nepal
18
Nigeria
18
Zambia
18
Uganda
16
Bangladesh
15
Malawi
14
Philippines
14
Rwanda
12
Ghana
11
Peru
11
Sierra Leone
10
Asia
10
South–East Asia Region
10
Liberia
10
Colombia
9
Zimbabwe
9
Ukraine
8
Mozambique
8
Cambodia
8
Argentina
7
Lesotho
6
Brazil
6
Russia
6
Namibia
6
Myanmar / Burma
6
Eswatini/ Swaziland
6
Germany
5
Western Pacific Region
5
Bolivia
5
Botswana
5
Pakistan
5
Tajikistan
4
El Salvador
4
Cameroon
4
Senegal
4
Venezuela
4
Spain
4
Syria
3
Albania
3
Laos
3
Burkina Faso
3
USA
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
Uruguay
3
Lebanon
3
Vietnam
3
Sudan
3
Thailand
2
Turkey
2
Chile
2
Fiji
2
Afghanistan
2
Morocco
2
Armenia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Georgia
2
Angola
2
Bhutan
2
Indonesia
2
Iraq
2
Ecuador
2
North Macedonia
1
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Gambia
1
China
1
Iran
1
Qatar
1
Haiti
1
Ireland
1
West and Central Africa
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Greece
1
Honduras
1
Mali
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
409
Clinical Guidelines
166
Public Health
63
Women & Child Health
27
Pharmacy & Technologies
22
Key Resources
20
Capacity Building
16
Toolboxes
TB
379
AMR
197
HIV
101
COVID-19
49
NTDs
44
Mental Health
40
Rapid Response
39
Planetary Health
25
Pharmacy
20
Refugee
15
Ebola
15
Global Health Education
14
Caregiver
12
NCDs
11
Polio
11
Natural Hazards
8
Cholera
8
Conflict
7
Specific Hazards
6
Disability
4
Zika
3
Recommendations from the American Nurses Association/Centers for Disease Control and Prevention Workgroup on the Role of Registered Nurses in Hospital Antibiotic Stewardship Practices
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
In this era, grand challenges lies in biodiversity loss, climate change, and global noncommunicable diseases signify that planet and humanity are in crisis. Scholarly evidence from human and animal kingdom suggest that there is an optimism in planetary health which can provide a unique and novel con...
Updated Treatment Guidelines
